Abivax SA (ABVX)
120.93
+3.83
(+3.27%)
USD |
NASDAQ |
Jan 20, 10:49
Abivax EPS Diluted (Quarterly): -2.457 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| DBV Technologies SA | -1.207 |
| Inventiva SA | -- |
| Cellectis SA | 0.0058 |
| Innate Pharma SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -179.21M |
| Total Expenses (Quarterly) | 179.21M |